AbD Serotec Joins Bio-Rad Laboratories
Feb 26, 2013
Bio-Rad Laboratories, Inc. recently completed the acquisition of AbD Serotec, formerly a division of MorphoSys AG. Bio-Rad has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets.
Bio-Rad Acquires AbD Serotec
Jan 10, 2013
HERCULES, CA – January 10, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has purchased AbD Serotec, a division of MorphoSys AG, for approximately 53 million euros in cash.